Cilnical
Generic Name
Cilnidipine
Manufacturer
Square Pharmaceuticals Ltd.
Country
Bangladesh
Loading images...
Price Details
Current market pricing information
| Variant | Unit Price | Strip Price |
|---|---|---|
| cilnical 10 mg tablet | ৳ 9.00 | ৳ 90.00 |
Description
Overview of the medicine
Cilnical 10 mg Tablet contains Cilnidipine, a dihydropyridine calcium channel blocker used to treat essential hypertension.
Uses & Indications
Dosage
Adults
Initially 5-10 mg once daily, adjusted based on response up to a maximum of 20 mg daily.
Elderly
Start with lower doses (e.g., 5 mg once daily) and titrate carefully.
Renal_impairment
No dose adjustment usually required for mild to moderate impairment. Use with caution in severe impairment.
How to Take
Oral. Take with or without food. Preferably at the same time each day.
Mechanism of Action
Cilnidipine blocks both L-type and N-type voltage-dependent calcium channels, leading to vasodilation and reduced blood pressure.
Pharmacokinetics
Onset
Within 1-2 hours
Excretion
Primarily excreted as metabolites in feces (approx. 60%) and urine (approx. 40%).
Half life
Approximately 5-8 hours
Absorption
Rapidly absorbed after oral administration. Peak plasma concentration typically within 1.5-3 hours. Bioavailability is around 13-25%.
Metabolism
Extensively metabolized in the liver, primarily by CYP3A4.
Side Effects
Contraindications
- Hypersensitivity to Cilnidipine or other dihydropyridine derivatives
- Cardiogenic shock
- Unstable angina
- Recent myocardial infarction
Drug Interactions
CYP3A4 inducers
May decrease Cilnidipine plasma concentrations (e.g., rifampicin, phenytoin).
CYP3A4 inhibitors
May increase Cilnidipine plasma concentrations (e.g., ketoconazole, erythromycin).
Other antihypertensives
Additive hypotensive effect.
Storage
Store below 30°C in a dry place, away from light and moisture. Keep out of reach of children.
Overdose
Symptoms may include marked hypotension and reflex tachycardia. Treatment is supportive and symptomatic; IV fluids and vasopressors may be needed.
Pregnancy & Lactation
Pregnancy Category C. Use only if potential benefit outweighs risk. Excretion in human milk is unknown, use with caution.
Frequently Asked Questions
Common questions about this medicine
Pack Sizes
Shelf Life
24 months from manufacturing date.
Availability
Pharmacies, hospitals
Approval Status
Approved by national regulatory authorities
Patent Status
Off-patent
Clinical Trials
Several clinical trials have demonstrated the efficacy and safety of Cilnidipine in treating hypertension, often highlighting its beneficial effects on renal function and sympathetic nervous activity compared to other CCBs.
Lab Monitoring
- Blood pressure
- Heart rate
- Renal function tests (periodically)
Doctor Notes
- Cilnidipine, a unique N/L-type CCB, may offer benefits over L-type CCBs in certain patients, especially those with renal impairment or sympathetic overactivity. Monitor for ankle edema.
- Consider its dual calcium channel blocking action for broader cardiovascular benefits.
Patient Guidelines
- Take as directed by your doctor.
- Do not stop suddenly without consulting your doctor.
- Monitor blood pressure regularly.
Missed Dose Advice
Take the missed dose as soon as you remember, unless it is almost time for your next dose. Do not double the dose.
Driving Precautions
May cause dizziness; avoid driving or operating machinery if affected.
Lifestyle Advice
- Maintain a healthy diet, limit salt intake.
- Engage in regular exercise.
- Avoid smoking and excessive alcohol consumption.
Alternative Medicines in Bangladesh
Similar medicines available in the market
Global Brand Names
International brand names for this medicine
Related
Medicines
Explore similar medicines to find the best option for your healthcare needs.
Avilam
Various (e.g., Sanofi as Avil)
Exib
Incepta Pharmaceuticals Ltd.
Avolose
Incepta Pharmaceuticals Ltd.
Axxo
Square Pharmaceuticals Ltd.
Exopan
Square Pharmaceuticals Ltd.
Azi S
Square Pharmaceuticals Ltd.
Exomi MUPS
Square Pharmaceuticals Ltd.
Lotenate Plus
General Pharmaceuticals Ltd.
Exalin
Square Pharmaceuticals Ltd.
Evoloxin
Incepta Pharmaceuticals Ltd.